Close this search box.
Subscriber Log In


Catch up with our insights on the big issues in pharma.

Our thought leadership library brings you our latest data-driven reports, infographics and articles that tackle the big issues, interesting niches and everything in between.

Latest Content

Analysis: Which Pharma Companies are Making Their Money Work?
As pharmaceutical companies decide how to allocate cash to ensure a steady flow of new treatments, how much of their revenue should go back into research and development, and how much into acquiring promising startups? The challenge is to ensure that...
Read More
The 2024 Freshness Index: Who Needs To Freshen Up?
To keep revenue flowing, Big Pharma companies must continuously introduce new therapies to replace older drugs with expiring patents. What’s the current landscape, and how might it shift going forward? Evaluate’s 2024 Freshness Index looks at the proportion...
Read More
Evaluating Radiopharmaceuticals
Radiopharmaceuticals have lit up – possibly even sparking more interest than antibody-drug conjugates, which have seen significant M&A activity in recent months. Strong data from Novartis’ oncology treatments, Lutathera and Pluvicto, coupled...
Read More
More content

Featured Contributors